This article is available online at http://www.jlr.org Supplementary key words glycerophospholipid profi le • mesenchymal stem cell • arachidonic acid • docosahexaenoic acid • lipid signaling • mass spectrometry Human mesenchymal stem/stromal cells (hMSC) are currently being studied in a number of clinical applications, for example, to improve the engraftment of hematopoietic stem cell transplant, to promote myocardial repair, and to control immunological responses in graft versus host diseases, autoimmune diseases, and solid organ transplantations ( 1-5 ). In addition to being immunologically privileged, these cells can modulate both innate and adaptive immune responses in vitro and in vivo. hMSCs have been shown to be able to inhibit T-cell proliferation, inhibit dendritic cell maturation ( 6 ), recruit regulatory T-cells ( 7,8 ), and modulate B-cell functions ( 9 ). The mechanisms by which these cells exert their immune modulatory functions are still unclear, but it is likely that both direct cell-cell contacts and the secretion of soluble factors are needed. Several cytokines, growth factors, enzymes, and lipid mediators, such as transforming growth factor  1, the